Enovis CORP (ENOV)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $27.22
- As of
Kresmion compiles this page from ENOV's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Enovis CORP (ENOV): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-05.
See the full ENOV dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ENOV on one page. Preview it with sample data, then open it live with a free account.
Preview the ENOV dossierActive events for ENOV
- mediumEarnings above estimates
Q3-2026: Beat consensus by 12.1%, EPS $0.88 vs $0.7852 estimate
- high13F: large reduction
CITADEL ADVISORS LLC cut 71% of ENOV (2026Q2)
- high13F: large increase
Bridgewater Associates, LP added +50% to ENOV (2026Q2)
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +51% to ENOV (2026Q1)
- medium13F: new position
Bridgewater Associates, LP new position in ENOV
FREE, NO ACCOUNT
Every event on ENOV, as it fires
You are seeing 5 of 10 events recorded on ENOV since 2026-05-29.
The five above landed across 3 days. The other 5 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, ENOV
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
More data on ENOV
ENOV against its peers
ENOV's operating margin of -50.0% ranks in the 32nd percentile of 19 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.
| Metric | ENOV | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.2B USD | 225M USD | 93 | 19 |
| Gross margin | 59.8% | 66.9% | 45 | 18 |
| Operating margin | -50.0% | -16.6% | 33 | 19 |
| Net margin | -52.7% | -10.4% | 28 | 19 |
| Return on equity | -79.5% | -11.0% | 13 | 18 |
| P / E | n/a | 34.1x | n/a | 5 |
| 1 year | 2.8% | 53.2% | 24 | 18 |
Peers (19): BFLY, ESTA, AVNS.D, IART, SIBN, UFPT, CBLL, NEOG, AORT, BBNX, KIDS, AXGN, INMD, QDEL, DCTH, TCMD, SENS, RCEL, MASS. Left out: NHNKF (no annual filing), LMRI (no annual filing), OSSUY (no annual filing), ALMR (no annual filing), MOBI (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (ENOV: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in ENOV on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ENOV in the last 180 days.
Upstream: SEC EDGAR filings for ENOV
Kresmion, "Enovis CORP (ENOV) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/ENOV. Upstream data: SEC EDGAR filings for ENOV.
Link to this data (HTML):
<a href="https://kresmion.com/research/ENOV">Enovis CORP (ENOV) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow ENOV on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ENOV for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.